دورية أكاديمية

Regulation of human GDNF gene expression in nigral dopaminergic neurons using a new doxycycline-regulated NTS-polyplex nanoparticle system.

التفاصيل البيبلوغرافية
العنوان: Regulation of human GDNF gene expression in nigral dopaminergic neurons using a new doxycycline-regulated NTS-polyplex nanoparticle system.
المؤلفون: Espadas-Alvarez, Armando J., Bannon, Michael J., Orozco-Barrios, Carlos E., Escobedo-Sanchez, Lourdes, Ayala-Davila, Jose, Reyes-Corona, David, Soto-Rodriguez, Guadalupe, Escamilla-Rivera, Vicente, De Vizcaya-Ruiz, Andrea, Eugenia Gutierrez-Castillo, M., Padilla-Viveros, America, Martinez-Fong, Daniel
المصدر: Nanomedicine: Nanotechnology, Biology & Medicine; May2017, Vol. 13 Issue 4, p1363-1375, 13p
مصطلحات موضوعية: PARKINSON'S disease treatment, GLIAL cell line-derived neurotrophic factor, NEUROTROPHINS, GENETIC transformation, NEUROTENSIN, NANOSTRUCTURED materials, NANOPARTICLES
مستخلص: The human glial-cell derived neurotrophic factor (hGDNF) gene transfer by neurotensin (NTS)-polyplex nanoparticles functionally restores the dopamine nigrostriatal system in experimental Parkinson's disease models. However, high levels of sustained expression of GDNF eventually can cause harmful effects. Herein, we report an improved NTS-polyplex nanoparticle system that enables regulation of hGDNF expression within dopaminergic neurons. We constructed NTS-polyplex nanoparticles containing a single bifunctional plasmid that codes for the reverse tetracycline-controlled transactivator advanced (rtTA-Adv) under the control of NBRE3x promoter, and for hGDNF under the control of tetracycline-response element (TRE). Another bifunctional plasmid contained the enhanced green fluorescent protein (GFP) gene. Transient transfection experiments in N1E-115-Nurr1 cells showed that doxycycline (100 ng/mL) activates hGDNF and GFP expression. Doxycycline (5 mg/kg, i.p.) administration in rats activated hGDNF expression only in transfected dopaminergic neurons, whereas doxycycline withdrawal silenced transgene expression. Our results offer a specific doxycycline-regulated system suitable for nanomedicine-based treatment of Parkinson's disease. [ABSTRACT FROM AUTHOR]
Copyright of Nanomedicine: Nanotechnology, Biology & Medicine is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Supplemental Index
الوصف
تدمد:15499634
DOI:10.1016/j.nano.2017.02.006